We are live on ! Find out more
PCS

Personal CFO Solutions Portfolio holdings

AUM $712M
1-Year Est. Return 25.3%
This Fund
S&P 500
This Quarter Est. Return
+6.81%
1 Year Est. Return
+25.3%
3 Year Est. Return
+74.76%
5 Year Est. Return
+83.43%
10 Year Est. Return
AUM
$349M
AUM Growth
+$98.1M
Cap. Flow
+$83.8M
Cap. Flow %
24%
Top 10 Hldgs %
35.55%
Holding
391
New
104
Increased
95
Reduced
118
Closed
48

Sector Composition

Rank Sector Weight
1 Industrials 16.37%
2 Financials 10.75%
3 Technology 7.86%
4 Healthcare 7.54%
5 Communication Services 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HBI
326
DELISTED
Hanesbrands
HBI
$162K 0.05%
10,901
-17,688
-62% -$269K
BRFS
327
DELISTED
BRF SA
BRFS
$134K 0.04%
15,375
+324
+2% +$2.79K
LYG icon
328
Lloyds Banking Group
LYG
$85.4B
$125K 0.04%
37,912
-2,531
-6% -$7.66K
GE icon
329
GE Aerospace
GE
$354B
$122K 0.03%
2,197
-45
-2% -$2.33K
BCRX icon
330
BioCryst Pharmaceuticals
BCRX
$2.32B
$110K 0.03%
+32,000
New +$80.5K
ABEV icon
331
Ambev
ABEV
$47.6B
$73K 0.02%
15,670
-110
-0.7% -$488
FOCL
332
EDAP TMS S.A.
FOCL
$210M
$66K 0.02%
15,000
+3,500
+30% +$16.4K
BBVA icon
333
Banco Bilbao Vizcaya Argentaria
BBVA
$139B
$62K 0.02%
11,104
-3,759
-25% -$20K
SAN icon
334
Banco Santander
SAN
$191B
$57K 0.02%
14,431
-1,360
-9% -$5.28K
ACB
335
Aurora Cannabis
ACB
$160M
$50K 0.01%
193
-45
-19% -$16.8K
OVV icon
336
Ovintiv
OVV
$16.2B
$50K 0.01%
2,128
+113
+6% +$2.42K
NIO icon
337
NIO
NIO
$12.1B
$40K 0.01%
10,000
VSTM icon
338
Verastem
VSTM
$505M
$40K 0.01%
2,500
+1,667
+200% +$24K
UMC icon
339
United Microelectronic
UMC
$50.9B
$38K 0.01%
14,130
AVEO
340
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$34K 0.01%
+5,390
New +$39.7K
BLCM
341
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$32K 0.01%
+2,450
New +$22.6K
NBRV
342
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$26K 0.01%
80
+16
+25% +$7.34K
RNTX
343
Rein Therapeutics
RNTX
$72.2M
$21K 0.01%
+1,850
New +$18.3K
ACGL icon
344
Arch Capital
ACGL
$35.6B
-7,300
Closed -$306K
ALLY icon
345
Ally Financial
ALLY
$14B
-7,878
Closed -$261K
BOCT icon
346
Innovator US Equity Buffer ETF October
BOCT
$284M
-39,742
Closed -$988K
CC icon
347
Chemours
CC
$2.58B
-31,493
Closed -$480K
CHKP icon
348
Check Point Software Technologies
CHKP
$14.1B
-1,964
Closed -$215K
CIG icon
349
CEMIG Preferred Shares
CIG
$6.15B
-78,266
Closed -$135K
CXSE icon
350
WisdomTree Trust WisdomTree China ex-State-Owned Enterprises Fund
CXSE
$487M
-19,678
Closed -$699K

Similar funds

Personal CFO Solutions's Q4 2019 Portfolio in Review

As of Q4 2019, Personal CFO Solutions held 391 positions worth $349M, up 39% from $251M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Personal CFO Solutions deployed $83.8M of net new capital in Q4 2019, opening 104 new positions and adding to 95 existing holdings. Its largest new stake was Boeing: 61,815 shares worth $20.1M.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, up from 4% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Innovator US Equity Buffer ETF August, an estimated $3.32M trimmed.

  • Personal CFO Solutions's largest Q4 2019 buy was Boeing: 61,815 shares worth $20.1M.
  • Personal CFO Solutions added most to State Street SPDR Bloomberg Investment Grade Floating Rate ETF in Q4 2019, an estimated $2.14M increase.
  • Personal CFO Solutions's biggest Q4 2019 reduction was Innovator US Equity Buffer ETF August, cutting an estimated $3.32M.
  • Personal CFO Solutions fully exited Fidelity MSCI Consumer Staples Index ETF in Q4 2019, selling an estimated $3.96M.
  • Personal CFO Solutions's ten largest holdings make up 36% of its $349M portfolio in Q4 2019.
  • Personal CFO Solutions opened 104 new positions and closed 48 in Q4 2019.
  • Personal CFO Solutions's portfolio value rose 39% quarter-over-quarter to $349M.

Based on Personal CFO Solutions's 13F filing for Q4 2019, filed 13 Feb 2020.